Repare Therapeutics Ownership | Who Owns Repare Therapeutics?


OverviewForecastRevenueFinancialsChart

Repare Therapeutics Ownership Summary


Repare Therapeutics is owned by 16.84% institutional investors, 0.25% insiders, and 82.90% retail investors. Aquilo capital management is the largest institutional shareholder, holding 3.05% of RPTX shares. ARK Genomic Revolution ETF is the top mutual fund, with 2.65% of its assets in Repare Therapeutics shares.

RPTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRepare Therapeutics16.84%0.25%82.90%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Aquilo capital management1.29M3.05%$1.69M
Mpm asset management1.12M2.61%$1.97M
Bioimpact capital819.92K1.91%$1.44M
Millennium management170.96K0.40%$223.96K
Blackrock141.80K0.34%$467.95K
Militia capital partners, lp119.18K0.28%$209.75K
Two sigma advisers, lp27.70K0.06%$48.75K
Blackstone25.96K0.06%$45.68K
Bank of america corp /de/10.25K0.02%$33.84K
Citadel advisors1.40K0.00%$4.62K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mpm asset management1.12M4.43%$1.97M
Aquilo capital management1.29M2.56%$1.69M
Bioimpact capital819.92K0.24%$1.44M
Militia capital partners, lp119.18K0.10%$209.75K
Blackstone25.96K0.00%$45.68K
Millennium management170.96K0.00%$223.96K
Two sigma advisers, lp27.70K0.00%$48.75K
Renaissance---
Pdt partners---
National bank of canada /fi/---

Top Buyers

HolderShares% AssetsChange
Aquilo capital management1.29M2.56%304.35K
Blackrock141.80K-80.54K
Millennium management170.96K0.00%67.64K
Blackstone25.96K0.00%-
Two sigma advisers, lp27.70K0.00%-

Top Sellers

HolderShares% AssetsChange
Bvf inc/il---10.33M
Blue owl capital lp---3.44M
Orbimed advisors---3.32M
Versant venture management---2.65M
Redmile group---1.59M

Sold Out

HolderChange
Bnp paribas arbitrage, snc-1.00
Jpmorgan chase-4.00
Steward partners investment advisory-11.00
Jones financial companies lllp-100.00
Royal bank of canada-200.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202528-37.78%7,235,847-73.47%160.42%12-5-
Sep 30, 202522-53.19%8,070,778-69.88%180.48%3-81.25%2-80.00%
Jun 30, 2025514.08%27,751,9247.80%641.77%19-10-33.33%
Mar 31, 202551-5.56%29,511,633-3.64%691.33%20-16-15.79%
Dec 31, 202424-57.89%6,082,941-81.22%140.25%9-52.63%7-61.11%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
ARK Genomic Revolution ETF1.13M2.65%-1.65K
ARK Genomic Revolution1.10M2.59%-872.23K
Nikko Gbl All Biological Genome Eq MF297.64K0.70%-28.36K
A4Investments SICAV SIF ACCI IlanaA2EURH160.00K0.38%-
Northern Small Cap Core I77.83K0.18%-5.85K
Vanguard Health Care ETF52.52K0.12%231.00
Biotech Growth Ord49.26K0.11%-
Range Cancer Therapeutics ETF47.41K0.11%-
Vifag 2002 SICAV35.00K0.08%-
NT Quality SCC US Fund - L23.17K0.05%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 12, 2025Koehler Maria EVP, CHIEF MEDICAL OFFICERSell$4.10K
Mar 12, 2025Zinda Michael EVP, CHIEF SCIENTIFIC OFFICERSell$6.40K
Mar 12, 2025Forte Steve EVP, CHIEF FINANCIAL OFFICERSell$7.85K
Mar 12, 2025Segal Lloyd Mitchell PRESIDENT AND CEOSell$24.14K
Mar 28, 2024Segal Lloyd Mitchell PRESIDENT AND CEOSell$12.24K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q2--
2025 Q1-4
2024 Q2-4
2024 Q1-16

RPTX Ownership FAQ


Who Owns Repare Therapeutics?

Repare Therapeutics shareholders are primarily institutional investors at 16.84%, followed by 0.25% insiders and 82.91% retail investors. The average institutional ownership in Repare Therapeutics's industry, Biotech Stocks , is 35.75%, which Repare Therapeutics falls below.

Who owns the most shares of Repare Therapeutics?

Repare Therapeutics’s largest shareholders are Aquilo capital management (1.29M shares, 3.05%), Mpm asset management (1.12M shares, 2.61%), and Bioimpact capital (819.92K shares, 1.91%). Together, they hold 7.57% of Repare Therapeutics’s total shares outstanding.

Does Blackrock own Repare Therapeutics?

Yes, BlackRock owns 0.34% of Repare Therapeutics, totaling 141.8K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 467.95K$. In the last quarter, BlackRock increased its holdings by 80.54K shares, a 131.46% change.

Who is Repare Therapeutics’s biggest shareholder by percentage of total assets invested?

Mpm asset management is Repare Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.43% of its assets in 1.12M Repare Therapeutics shares, valued at 1.97M$.

Who is the top mutual fund holder of Repare Therapeutics shares?

ARK Genomic Revolution ETF is the top mutual fund holder of Repare Therapeutics shares, with 2.65% of its total shares outstanding invested in 1.13M Repare Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools